Remote Jobs at Sanguine BioSciences
Sanguine BioSciences is a medical research services company.
What They Do
Sanguine BioSciences provides clients with in-home sample collection services. This company partners with medical research groups to expedite clinical trials and provide access to a wider patient base.
This employer frequently offers telecommuting job opportunities. Remote candidates may have flexible work schedules.
Remote Jobs
At the time of our research, we discovered remote jobs for a senior Salesforce administrator, a patient support coordinator I, a head of product - life sciences, an associate director of field operations, and a technical/medical writer.
Remote Tools Used
- Salesforce
- Google Workspace
- Tableau
Research Findings
- We found nine full-time remote positions available at the time of our research
- Based on our research, Sanguine BioSciences values candidates who have great interpersonal skills
- Our research showed that Sanguine BioSciences hires people who are highly organized
- Job researchers discovered that this company offers competitive benefits and salary
- Application method: Applicant Tracking Software
Join Our Community Today
- Largest screened remote jobs database.
- Save time. We research the jobs for you.
- New remote jobs posted daily.
- Search our database and start applying.
The Analyzers: Single-cell Superheroes of Therapy Development
The Analyzers: Single-cell Superheroes of Therapy Development Supporting the single-cell revolution
Sanguine Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research
Comprehensive and real-time electronic health records shorten study timelines and offer new product
Pick Preferred Specimens to Perfect Immune Profiling
Simple, underappreciated solutions for reliable flow cytometry data and longitudinal study design
Powering Precise Protein Assays
Standardizing the procurement of translational biospecimens reduces variability and strengthens
Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene